This regularly scheduled sponsored Q&A column is written by Eli Tucker, Arlington-based Realtor and Arlington resident. Please submit your questions to him via email for response in future columns.

Eli Lilly raised its full-year 2021 profit and sales expectations on Wednesday, helped partly by a recent U.S. government contract for its COVID-19 antibody treatment. Adds forecast details, shares ...

Drug maker Eli Lilly’s share price plunged Wednesday morning after the company reported worse third-quarter results than expected, especially in its weight-loss drug division, registering a rare ...

Since the beginning of 2017, Eli Lilly's has outperformed all other big pharmaceutical companies. Lots of popular new drugs are responsible for Eli Lilly's outperformance in recent years, and the ...

This regularly scheduled sponsored Q&A column is written by Eli Tucker, Arlington-based Realtor and Arlington resident. Please submit your questions to him via email for response in future columns.